Justice Department Investigates Healthcare Fraud in Child Transgender Procedures
The Justice Department is probing healthcare fraud related to sex change procedures for minors, issuing subpoenas to involved doctors and clinics.
Overview
- The Justice Department is investigating healthcare fraud linked to sex change procedures for minors.
- The investigation targets doctors and clinics providing these procedures, focusing on potential fraud and false statements.
- Over 20 subpoenas have been issued to healthcare providers suspected of performing transgender medical procedures on children.
- The Federal Trade Commission is also examining potential consumer protection law violations in the gender medicine sector.
- This investigation highlights growing scrutiny over medical practices related to transgender care for minors.
Report issue
Read both sides in 5 minutes each day
Analysis
Center-leaning sources frame the Justice Department's actions as a significant intervention in child transgender medical procedures, reflecting a cautious stance towards these practices. The language suggests concern over regulatory oversight, indicating a bias towards accountability while also hinting at broader societal debates surrounding transgender healthcare for minors.
"The move is likely to heighten fears for transgender youth who receive gender-affirming medical care, after a series of Republican-led states have banned such treatments for minors."
USA TODAYArticles (3)
FAQ
Investigations focus on healthcare fraud statutes and the Food, Drug, and Cosmetic Act, which regulate the marketing and use of prescription drugs. The Department of Justice is also examining cases under consumer protection laws as enforced by the Federal Trade Commission. These actions follow executive orders and memoranda targeting federal funding and the legal limits of gender-affirming care for minors.
The investigations center on sex change procedures for minors, including the use of puberty blockers, sex hormones, and other drugs involved in gender-affirming care. Both the providers of these procedures and the manufacturers/distributors of related medications are being scrutinized.
Major medical organizations such as the American Medical Association and the American Academy of Pediatrics support gender-affirming care for youth. These groups maintain that evidence-based care for transgender minors is medically necessary and should be protected.
In June 2025, the U.S. Supreme Court ruled 6-3 to uphold Tennessee's law banning specific transgender medical treatments for adolescents. This decision has informed and reinforced federal efforts to restrict or investigate gender-affirming care for minors.
The Federal Trade Commission is examining whether providers or manufacturers have violated consumer protection laws, including prohibitions on unfair or deceptive practices related to the marketing and provision of gender-affirming care for minors.
History
- This story does not have any previous versions.